[vc_row css=”.vc_custom_1512431460697{margin-bottom: 0px !important;}”][vc_column width=”2/3″ el_class=”block1″][vc_column_text]
(Meningococcal Polysaccharide Vaccine)
(Group A, C, Y & W135)
Meningitis or Meningococcemia is caused by Neisseria meningitidis (Groups A, C, Y, W135) bacteria. It may be severe and life threatening. A variety of neurological and immunological complications are generally associated with the primary disease.
DESCRIPTION :
QUADRI MENINGO™ is to be used to protect against cerebrospinal meningitis caused by Neisseria meningitidis (Group A, C, Y & W 135). Quadri Meningo™ conforms to the I.P.
[/vc_column_text][/vc_column][vc_column width=”1/3″ el_class=”block2″][vc_single_image image=”3890″ img_size=”full” alignment=”center” el_class=”img”][/vc_column][/vc_row][vc_row el_class=”product-box” css=”.vc_custom_1512432424869{padding-top: 35px !important;}”][vc_column width=”1/3″ el_class=”block3″][vc_row_inner css=”.vc_custom_1512431727138{margin-top: 0px !important;margin-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”3346″ img_size=”24×24″ el_class=”img”][vc_column_text]COMPOSITION :
Each dose (0.5 ml) of vaccine contains :
| Particulars | Quantity |
| Purified Polysaccharide of Neisseria meningitidis Group A | 50 mcg |
| Purified Polysaccharide of Neisseria meningitidis Group C | 50 mcg |
| Purified Polysaccharide of Neisseria meningitidis Group Y | 50 mcg |
| Purified Polysaccharide of Neisseria meningitidis Group W 135 | 50 mcg |
| Lactose I.P. (Stabilizer) | 5 mg |
| Thimerosal I.P. (Preservative) | 0.05 mg |
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″ el_class=”block4″][vc_row_inner el_class=”product-border”][vc_column_inner][vc_single_image image=”3353″ img_size=”24×24″ el_class=”img”][vc_column_text]INDICATIONS :
- Hajj and Umrah pilgrims heading to Mecca, Saudi Arabia.
- Children and adults exposed to infected patients.
- Recommended for children above 18 months of age as routine immunization in endemic areas.
- Travellers heading to disease prone areas should be vaccinated at least 15 days in advance.
- Military recruits.
- During epidemic, children between 3-18 months need to be vaccinated 3 months apart. Revaccination is recommended in children at high risk areas who were vaccinated below 4 years of age.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″ el_class=”block5″][vc_row_inner css=”.vc_custom_1512429922882{margin-top: 0px !important;margin-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”3346″ img_size=”24×24″ el_class=”img”][vc_column_text]PRESENTATION :
QUADRI MENINGO™ is available in single dose vial with syringe and 10 dose vial packing along with appropriate diluent.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”product-box” css=”.vc_custom_1512432458076{padding-top: 35px !important;}”][vc_column width=”1/3″ el_class=”block6″][vc_row_inner css=”.vc_custom_1512429922882{margin-top: 0px !important;margin-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”3353″ img_size=”24×24″][vc_column_text]DOSAGE AND ADMINISTRATION :
Reconstitute the lyophilisate with the entire content of the diluent provided with vaccine vaccine. Inject 0.5 ml as S/C or I/M injection.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″ el_class=”block7″][vc_row_inner el_class=”product-border”][vc_column_inner][vc_single_image image=”3346″ img_size=”24×24″ el_class=”img”][vc_column_text]
CONTRA- INDICATION :
- Hypersensitivity to any of the vaccine component.
- Ongoing acute or chronic illness like fever, severe infection, persistent diarrhoea, vomiting.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″ el_class=”block8″][vc_row_inner css=”.vc_custom_1512429922882{margin-top: 0px !important;margin-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”3352″ img_size=”24×24″][vc_column_text]SIDE EFFECTS :
Reaction to vaccination generally consists of localized injection site reaction ( Pain , redness) , transient hyperthermia , headache,vomiting in children etc.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row el_class=”product-box” css=”.vc_custom_1512432608841{padding-top: 35px !important;}”][vc_column width=”1/3″ el_class=”block9″][vc_row_inner css=”.vc_custom_1512429922882{margin-top: 0px !important;margin-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”3346″ img_size=”24×24″][vc_column_text]STORAGE :
Store at 2° C to 8° C in refrigerator. Product is good to use for 24 months from the date of manufacture.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″ el_class=”block10″][vc_row_inner css=”.vc_custom_1512429922882{margin-top: 0px !important;margin-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”3353″ img_size=”24×24″][vc_column_text]OTHER INFORMATION :
W.H.O has recommended use of Quadrivalent Vaccine (containing A, C, Y & W 135) in place of bivalent vaccine (containing only A, C ) specially in areas like India where group specific meningococci – causing the disease have not been identified.
[/vc_column_text][/vc_column_inner][/vc_row_inner][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row][vc_row][vc_column css=”.vc_custom_1514805208841{background-color: #e8e8e8 !important;}”][vc_column_text]
- Package Insert ( Specifications as per WHO TRS
- Package Insert ( Specifications as per IP)
- PPD (Specifications as per WHO TRS)
- PPD ( Specifications as per I.P)
- SmPC ( Specifications as per WHO TRS)
- SmPC ( Specifications as per IP)
[/vc_column_text][/vc_column][/vc_row]
Leave a Reply